We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Valeant Tries to Contain Philidor Fallout, Reassure Skeptical Investors
Valeant Tries to Contain Philidor Fallout, Reassure Skeptical Investors
Valeant Pharmaceuticals executives tried to allay nervous investors in a hastily called conference call Nov. 10, following weeks of scandal and falling stock value. However, participants sounded skeptical of the company’s upbeat assessment.